Showing 771-780 of 3877 results for "".
Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).Advances in Retinoid Formulation
https://practicaldermatology.com/columns/clinical-focus-1/advances-in-retinoid-formulation/23408/A novel delivery system offers the efficacy of tazarotene, while minimizing irritation.Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis Patients
https://practicaldermatology.com/topics/research-update/monoclonal-antibodies-restoring-healthy-skin-microbiome-atopic-dermatitis-patients/24566/Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis PatientsGene Biomarker Research and Implications for Care
https://practicaldermatology.com/topics/psoriasis/gene-biomarker-research-and-implications-for-care/23374/A tape strip test can differentiate psoriasis from atopic dermatitis based on genetic analysis. How may the finding affect care?Collagen in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/collagen-atopic-dermatitis/27167/Kripa Ahuja, MS, and Peter Lio, MD, review a 2024 study from Szalsus et al. looking at the role of collagens in atopic dermatitis (AD).It is Time to Move Beyond Mushroom Tyrosinase. And Is Hydroquinone What We Think It Is?
https://practicaldermatology.com/topics/pigmentary-disorders/it-is-time-to-move-beyond-mushroom-tyrosinase-and-is-hydroquinone-what-we-think-it-is/23768/New research is offering better clinical clues about the action of tyrosinase inhibitors.Open Payments Program: Does it Enhance Open Discussion About Financial Ties Between Dermatologists and Industry?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/open-payments-program-does-it-enhance-open-discussion-about-financial-ties-between-dermatologists-and-industry/23619/The majority of physicians practicing in the United States have received some form of compensation from private industry during their careers. These payments may include consulting fees, compensation for speaking engagements, and stock options. Certain payments take indirect forms, such as physicPruritus: A Marker For Cancer?
https://practicaldermatology.com/topics/practice-management/pruritus-a-marker-for-cancer/21181/Though the relationship is well known, new studies validate concerns regarding the link between pruritus and malignancy.Analysis of Gene Mutations by QIAGEN Clinical Insight (QCI) Interpretation Tool
https://practicaldermatology.com/youngmd-connect/resident-resource-center/analysis-of-gene-mutations-by-qiagen-clinical-insight-qciinterpretation-tool/23086/Currents
https://practicaldermatology.com/topics/psoriasis/currents/21210/